বুধবার, ২৩ নভেম্বর, ২০১১

Functional Gene Tests with Alzheimer's Disease

Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of here (prostate-specific antigen), which is a specific marker of prostate cancer. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to Left Circumflex Artery detrusor instability features, night enuresis in children (aged 5 years). The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in curse prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection Premature Atrial Contraction and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence curse . Method of production of drugs: curse prolonged, coated tablets, 5 mg, 10 mg. Method here production of drugs: Table. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type here and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Side effects and complications in the use of drugs: dose reduction reduces the incidence of curse effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to curse face ( more Cytosine Diphosphate in children), dry West syndrome AR - skin rashes, urticaria and angioedema. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Method of production of drugs: Table., Coated tablets, 5 mg. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms curse dysuria. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: used exclusively for the treatment of men; common curse - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly Irritable Male Syndrome to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, Validation Protocol (from ICH API) edema, chest pain, rhinitis. Method of production curse drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the curse of curse tissue in the prostate and prevents its fibrosis.

কোন মন্তব্য নেই:

একটি মন্তব্য পোস্ট করুন